Qualitative and quantitative approaches to modelling tyrosine kinase inhibitor treatment and resistance in non-small cell lung cancer
<p>Non-small cell lung cancer (NSCLC) affects 80-85% of lung cancer patients. Tyrosine kinase inhibitors (TKIs) are targeted therapies that bind to NSCLC cells with specific mutations and inhibit their growth. However, responses to these therapies generally fail due to the emergence of drug re...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Language: | English |
Published: |
2021
|
Subjects: |